Cesano Alessandra
SEC Form 4 insider trading activity
Cesano Alessandra has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.
On the most recent filing, Cesano Alessandra is listed as Director at PUMA BIOTECHNOLOGY, INC. Inside the rolling window, Cesano Alessandra reported no open-market purchases and 1 open-market sale totaling $567K in PBYI.
Companies traded
Other insiders at PBYI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$567K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cesano Alessandra made?
Cesano Alessandra has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Cesano Alessandra trade?
Cesano Alessandra has filed SEC Form 4 disclosures for 1 company, including PBYI.
When was Cesano Alessandra's most recent SEC Form 4 filing?
Cesano Alessandra's most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.
What is Cesano Alessandra's total buy and sell value in the current window?
Inside the rolling retention window, Cesano Alessandra bought $0 and sold $567K based on SEC Form 4 filings.
What was Cesano Alessandra's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 62,150 PBYI shares on 2026-09-14, worth $567K, per SEC Form 4 filings.